ArticleDiabetes, obesity & metabolism2025

CONFIDENCE in the safety and efficacy of dual therapy with an SGLT-2 inhibitor and finerenone in patients with chronic kidney disease and type 2 diabetes.

Panagiotis I Georgianos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.